-
With the plethora of continuing medical education (CME) resources available to most physicians in the United States many of them free or paid for by employers it would appear that falsely reporting CME credits would be a pointless risk.
-
Accepted clinical therapies developed from embryonic stem cell research may be years away, but now is the time for health care providers to ask themselves where they stand on the use of treatments derived from human embryos.
-
A convicted murderer who sought a reprieve so he could donate his liver to his ill sister was executed in May after Indiana Gov. Mitch Daniel was advised by doctors that Gregory Scott Johnson was not a good candidate to be a donor, and that his sister, Debra Otis, would likely receive a donor organ through regular channels within a matter of months. Johnsons bid to become an organ donor resurrected debate about the ethics of accepting organs from condemned inmates.
-
Illinois has become the first state to enact legislation based on the idea that an apology might serve as the most effective means to stop some medical malpractice lawsuits.
-
The National Institutes of Health (NIH) found its sweeping new ethics changes were proving a hard pill for its employees to swallow. As a result, they supplemented it with proposals that respond to actual and threatened resignations by some of the key NIH employees who say the new regulation, which requires employees to divest themselves of outside consulting and investments with pharmaceutical and biotech industries, is too restrictive.
-
The use of opioids for pain relief is limited by what some have called opiophobia, or the fear that patients will become addicted to the drugs. The Veterans Health Administration (VHA) has spelled out a means of addressing the drawbacks to opioid therapy and reducing the fear of prescribing opioids.
-
Particularly at smaller institutions, IRB administrators who also serve as voting members can offer many benefits. They attend and coordinate all meetings, so counting them as members helps the board achieve quorum.
-
In the past few years, Hispanics have become the largest minority group in the United States, numbering nearly 41.3 million in the most recent U.S. Census estimates.
-
Only 75% of patients that begin clinical trials for drugs fully complete, according to a recent study by Cutting Edge Information in Research Triangle Park, NC, noting several reasons for this low completion rate.
-
Physicians discussing clinical trials with their patients may not realize the importance of patients fears about side effects in making a decision about whether to participate.
